Cancer- and chemotherapy-induced anemia

Journal of the National Comprehensive Cancer Network : JNCCN
George M RodgersAlva B Weir

Abstract

Anemia is prevalent in 30% to 90% of patients with cancer. Anemia can be corrected through either treating the underlying cause or providing supportive care through transfusion with packed red blood cells or administration of erythropoiesis-stimulating agents (ESAs), with or without iron supplementation. Recent studies showing detrimental health effects of ESAs sparked a series of FDA label revisions and a sea change in the perception of these once commonly used agents. In light of this, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer- and Chemotherapy-Induced Anemia underwent substantial revisions this year. The purpose of these NCCN Guidelines is twofold: 1) to operationalize the evaluation and treatment of anemia in adult cancer patients, with an emphasis on those who are receiving concomitant chemotherapy, and 2) to enable patients and clinicians to individualize anemia treatment options based on patient condition.

Citations

Dec 20, 2012·Anesthesiology·Lawrence Tim Goodnough, Aryeh Shander
Feb 18, 2014·American Journal of Hematology·Jeffrey A GilreathGeorge M Rodgers
Jun 27, 2015·American Journal of Hematology·Lawrence Tim Goodnough, Neil Shah
Oct 21, 2017·Current Medical Research and Opinion·Khaled M Musallam, Ali T Taher
Jun 20, 2020·Blood·Jeffrey A Gilreath, George M Rodgers
Jan 15, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·R ParameswaranG Soff
Oct 15, 2013·American Journal of Hematology·Lawrence Tim Goodnough, Stanley L Schrier
Dec 4, 2015·Korean journal of family medicine·Wan ParkJin-Young Shin
Jan 13, 2017·Journal of Cancer Research and Clinical Oncology·Constantinos E AlifierisDimitrios T Trafalis
Apr 10, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Antonino MafoddaR Maisano
Nov 23, 2017·United European Gastroenterology Journal·K V GrootemanJph Drenth
Jul 7, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Angélique SaintJ Barriere
Feb 23, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Gökçe KenarGüngör Utkan
Jul 4, 2012·Nature Reviews. Clinical Oncology·Charles S CleelandJamey Skillings
Feb 6, 2015·BioMed Research International·Yulia M SerebrennikovaLuis H Garcia-Rubio
Apr 4, 2016·Current Hematologic Malignancy Reports·Charlotte PawlynSikander Ailawadhi
Apr 15, 2018·Journal of Cachexia, Sarcopenia and Muscle·Traver J WrightMelinda Sheffield-Moore
Jan 19, 2018·International Journal of Oncology·Armin FrilleAndelko Hrzenjak
Dec 31, 2019·ESC Heart Failure·Markus S AnkerUNKNOWN Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology
Sep 29, 2020·Clinical Epidemiology·Søren Viborg VestergaardChristian Fynbo Christiansen
Oct 26, 2016·American Journal of Hematology·Lawrence Tim GoodnoughAryeh Shander
Oct 16, 2014·Expert Opinion on Biological Therapy·Massimo MartinoUNKNOWN European Society for Blood and Marrow Transplantation, Solid Tumors Working Party (EBMT-STWP)
Dec 22, 2020·American Journal of Clinical Pathology·Alexa TurgemanMajed A Refaai
Jan 20, 2021·Stem Cell Research & Therapy·Boyan WangAndy Peng Xiang
Feb 5, 2021·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Amal MameriMokrane Iguer-Ouada
Feb 3, 2021·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Ahmed Abu-ZaidIsmail A Al-Badawi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.